clopidogrel has been researched along with Transfusion Reaction in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fallon, E; Fratello, A; Romeiser, JL; Rosengart, TK; Senzel, L; Shroyer, AL; White, LJ | 1 |
DiNicolantonio, JJ; Serebruany, VL; Sibbing, D | 1 |
Brooke, BS; Conrad, MF; Goodney, PP; Jones, DW; Schermerhorn, ML; Stone, DH; Wyers, MC | 1 |
Alejo, D; Baumgartner, WA; Blasco-Colmenares, E; Conte, JV; Faraday, N; Guallar, E; Pastor-Barriuso, R; Perl, TM; Sharrett, AR | 1 |
1 review(s) available for clopidogrel and Transfusion Reaction
Article | Year |
---|---|
Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond.
Topics: Acute Lung Injury; Adenosine; Adenosine Monophosphate; Administration, Oral; Clopidogrel; Dyspnea; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Sulfonamides; Ticagrelor; Ticlopidine; Transfusion Reaction | 2014 |
3 other study(ies) available for clopidogrel and Transfusion Reaction
Article | Year |
---|---|
Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
Topics: Aged; Blood Platelets; Chi-Square Distribution; Clopidogrel; Coronary Artery Bypass; Decision Support Techniques; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Patient Selection; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Hemorrhage; Predictive Value of Tests; Preoperative Care; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Transfusion Reaction; Treatment Outcome | 2013 |
Perioperative clopidogrel is associated with increased bleeding and blood transfusion at the time of lower extremity bypass.
Topics: Aged; Blood Loss, Surgical; Blood Transfusion; Chi-Square Distribution; Clopidogrel; Databases, Factual; Drug Administration Schedule; Female; Hospital Mortality; Humans; Logistic Models; Lower Extremity; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Operative Time; Perioperative Period; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Reoperation; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Transfusion Reaction; Treatment Outcome; United States; Vascular Surgical Procedures | 2017 |
Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery.
Topics: Aged; Aspirin; Bacteremia; Blood Transfusion; Clopidogrel; Cohort Studies; Coronary Artery Bypass; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Surgical Wound Infection; Ticlopidine; Transfusion Reaction | 2009 |